Top

Mindfulness

Gepubliceerd in:

02-07-2021 | ORIGINAL PAPER

Effectiveness of Mindfulness-Based Cognitive Therapy for Positive Clinical Outcome in Panic Disorder: a 5-year Longitudinal Study

Auteurs: Minji Bang, Borah Kim, Kang Soo Lee, Tai Kiu Choi, Sang-Hyuk Lee

Gepubliceerd in: Mindfulness | Uitgave 9/2021

Abstract

Objectives

Mindfulness-based cognitive therapy (MBCT) as an adjunctive to pharmacotherapy (PT) has been suggested as a good treatment option for panic disorder (PD). However, its long-term effectiveness in generating positive treatment outcomes remains to be established. We assessed the long lasting effectiveness of adjunctive MBCT up to 5 years and the influence of genetic variations on treatment outcomes in patients with PD.

Methods

A total of 109 participants who received adjunctive MBCT to PT (MBCT + PT) and 109 age- and sex-matched patient controls (PT-alone) were followed up for relapse or aggravation of PD up to 5 years. The serotonin transporter gene-linked polymorphic region (5-HTTLPR), catechol-O-methyltransferase, and brain-derived neurotrophic factor polymorphisms were analyzed at baseline.

Results

Adjunctive MBCT significantly reduced the risk for relapse or aggravation of PD for up to 5 years. 5-HTTLPR polymorphism also had a significant positive effect on the long term outcome of PD; however, there was no therapygenetic effect on the benefits of adjunctive MBCT.

Conclusions

This 5-year follow-up study demonstrated the enduring therapeutic effects of MBCT adjunctive to PD for improving long-term treatment outcome in patients with PD. Furthermore, 5-HTTLPR polymorphism may be a moderator of treatment experiences that further boost treatment success. Future investigations are warranted to establish the clinical application of MBCT and the need for personalized treatment strategies to maintain positive outcomes in patients with PD.

vorige artikel The Buddha’s Awakening

volgende artikel The Relations Between Self-Compassion, Self-Coldness, and Psychological Functioning Among North American and Hong Kong College Students

Alleen toegankelijk voor geautoriseerde gebruikers

Aaronson, C. J., Shear, M. K., Goetz, R. R., Allen, L. B., Barlow, D. H., White, K. S., Ray, S., Money, R., Saksa, J. R., Woods, S. W., & Gorman, J. M. (2008). Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy. Journal of Clinical Psychiatry, 69(3), 418–424. https://doi.org/10.4088/jcp.v69n0312CrossRef

Austin, D. W., & Richards, J. C. (2001). The catastrophic misinterpretation model of panic disorder. Behaviour Research and Therapy, 39(11), 1277–1291. https://doi.org/10.1016/s0005-7967(00)00095-4CrossRefPubMed

Ballenger, J. C. (2001). Treatment of anxiety disorders to remission. Journal of Clinical Psychiatry, 62(Suppl 12), 5–9. https://www.ncbi.nlm.nih.gov/pubmed/11430617.

Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA, 283(19), 2529–2536. https://doi.org/10.1001/jama.283.19.2529CrossRefPubMed

Baumeister, R. F., Vohs, K. D., DeWall, C. N., & Zhang, L. (2007). How emotion shapes behavior: Feedback, anticipation, and reflection, rather than direct causation. Personality and Social Psychology Review, 11(2), 167–203. https://doi.org/10.1177/1088868307301033CrossRefPubMed

Baxter, A. J., Vos, T., Scott, K. M., Ferrari, A. J., & Whiteford, H. A. (2014). The global burden of anxiety disorders in 2010. Psychological Medicine, 44(11), 2363–2374. https://doi.org/10.1017/S0033291713003243CrossRefPubMed

Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory Manual. Psychological Corporation.

Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. Psychological Corporation.

Bishop, S. R., Lau, M., Shapiro, S., Carlson, L., Anderson, N. D., Carmody, J., Segal, Z. V., Abbey, S., Speca, M., & Velting, D. (2004). Mindfulness: A proposed operational definition. Clinical Psychology: Science and Practice, 11(3), 230–241.

Bruce, T. J., Spiegel, D. A., & Hegel, M. T. (1999). Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies. Journal of Consulting and Clinical Psychology, 67(1), 151–156. https://www.ncbi.nlm.nih.gov/pubmed/10028220.

Bruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., Shea, M. T., & Keller, M. B. (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. American Journal of Psychiatry, 162(6), 1179–1187. https://doi.org/10.1176/appi.ajp.162.6.1179CrossRef

Caspi, A., Hariri, A. R., Holmes, A., Uher, R., & Moffitt, T. E. (2010). Genetic sensitivity to the environment: The case of the serotonin transporter gene and its implications for studying complex diseases and traits. American Journal of Psychiatry, 167(5), 509–527. https://doi.org/10.1176/appi.ajp.2010.09101452CrossRef

Coleman, J. R., Lester, K. J., Keers, R., Roberts, S., Curtis, C., Arendt, K., Bogels, S., Cooper, P., Creswell, C., Dalgleish, T., Hartman, C. A., Heiervang, E. R., Hotzel, K., Hudson, J. L., In-Albon, T., Lavallee, K., Lyneham, H. J., Marin, C. E., Meiser-Stedman, R., … Eley, T. C. (2016). Genome-wide association study of response to cognitive-behavioural therapy in children with anxiety disorders. British Journal of Psychiatry, 209(3), 236–243. https://doi.org/10.1192/bjp.bp.115.168229CrossRef

de Jonge, P., Roest, A. M., Lim, C. C., Florescu, S. E., Bromet, E. J., Stein, D. J., Harris, M., Nakov, V., Caldas-de-Almeida, J. M., Levinson, D., Al-Hamzawi, A. O., Haro, J. M., Viana, M. C., Borges, G., O’Neill, S., de Girolamo, G., Demyttenaere, K., Gureje, O., Iwata, N., … Scott, K. M. (2016). Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys. Depression and Anxiety, 33(12), 1155–1177. https://doi.org/10.1002/da.22572CrossRefPubMedPubMedCentral

Eley, T. C., Hudson, J. L., Creswell, C., Tropeano, M., Lester, K. J., Cooper, P., Farmer, A., Lewis, C. M., Lyneham, H. J., Rapee, R. M., Uher, R., Zavos, H. M., & Collier, D. A. (2012). Therapygenetics: The 5HTTLPR and response to psychological therapy. Molecular Psychiatry, 17(3), 236–237. https://doi.org/10.1038/mp.2011.132CrossRefPubMed

Executive Committee for Korean Medication Algorithm for Panic Disorder. (2008). Korean medication algorithm for panic disorder 2008. ML Communication.

Ferguson, J. M., Khan, A., Mangano, R., Entsuah, R., & Tzanis, E. (2007). Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release. Journal of Clinical Psychiatry, 68(1), 58–68. https://doi.org/10.4088/jcp.v68n0108CrossRef

First, M. B., Spitzer, R. L., Miriam, G., & Williams, J. B. W. (2002). Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P). Biometrics Research, New York State Psychiatric Institute.

Fullana, M. A., Alonso, P., Gratacos, M., Jaurrieta, N., Jimenez-Murcia, S., Segalas, C., Real, E., Estivill, X., & Menchon, J. M. (2012). Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder. European Psychiatry, 27(5), 386–390. https://doi.org/10.1016/j.eurpsy.2011.09.005CrossRefPubMed

Furukawa, T. A., Katherine Shear, M., Barlow, D. H., Gorman, J. M., Woods, S. W., Money, R., Etschel, E., Engel, R. R., & Leucht, S. (2009). Evidence-based guidelines for interpretation of the panic disorder severity scale. Depression and Anxiety, 26(10), 922–929. https://doi.org/10.1002/da.20532CrossRefPubMedPubMedCentral

Greeson, J., & Brantley, J. (2009). Mindfulness and anxiety disorders: Developing a wise relationship with the inner experience of fear. In Clinical handbook of mindfulness (pp. 171–188). Springer.

Haase, C. M., Beermann, U., Saslow, L. R., Shiota, M. N., Saturn, S. R., Lwi, S. J., Casey, J. J., Nguyen, N. K., Whalen, P. K., Keltner, D., & Levenson, R. W. (2015). Short alleles, bigger smiles? The effect of 5-HTTLPR on positive emotional expressions. Emotion, 15(4), 438–448. https://doi.org/10.1037/emo0000074CrossRefPubMedPubMedCentral

Hayasaka, Y., Purgato, M., Magni, L. R., Ogawa, Y., Takeshima, N., Cipriani, A., Barbui, C., Leucht, S., & Furukawa, T. A. (2015). Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of Affective Disorders, 180, 179–184. https://doi.org/10.1016/j.jad.2015.03.021CrossRefPubMed

Hedman, E., Andersson, E., Ljotsson, B., Andersson, G., Andersson, E., Schalling, M., Lindefors, N., & Ruck, C. (2012). Clinical and genetic outcome determinants of internet- and group-based cognitive behavior therapy for social anxiety disorder. Acta Psychiatrica Scandinavica, 126(2), 126–136. https://doi.org/10.1111/j.1600-0447.2012.01834.xCrossRefPubMed

Helton, S. G., & Lohoff, F. W. (2015). Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders. Pharmacogenomics, 16(5), 541–553. https://doi.org/10.2217/pgs.15.15CrossRefPubMed

Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5), 427–440. https://doi.org/10.1007/s10608-012-9476-1CrossRefPubMedPubMedCentral

Homberg, J. R., Schubert, D., Asan, E., & Aron, E. N. (2016). Sensory processing sensitivity and serotonin gene variance: Insights into mechanisms shaping environmental sensitivity. Neuroscience & Biobehavioral Reviews, 71, 472–483. https://doi.org/10.1016/j.neubiorev.2016.09.029CrossRef

Houck, P. R., Spiegel, D. A., Shear, M. K., & Rucci, P. (2002). Reliability of the self-report version of the panic disorder severity scale. Depression and Anxiety, 15(4), 183–185. https://doi.org/10.1002/da.10049CrossRefPubMed

Kabat-Zinn, J., Massion, A. O., Kristeller, J., Peterson, L. G., Fletcher, K. E., Pbert, L., Lenderking, W. R., & Santorelli, S. F. (1992). Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. American Journal of Psychiatry, 149(7), 936–943. https://doi.org/10.1176/ajp.149.7.936CrossRef

Kato, M., & Serretti, A. (2010). Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Molecular Psychiatry, 15(5), 473–500. https://doi.org/10.1038/mp.2008.116CrossRefPubMed

Kim, B., Cho, S. J., Lee, K. S., Lee, J. Y., Choe, A. Y., Lee, J. E., Choi, T. K., & Lee, S. H. (2013). Factors associated with treatment outcomes in mindfulness-based cognitive therapy for panic disorder. Yonsei Medical Journal, 54(6), 1454–1462. https://doi.org/10.3349/ymj.2013.54.6.1454CrossRefPubMedPubMedCentral

Kim, B., Lee, S. H., Kim, Y. W., Choi, T. K., Yook, K., Suh, S. Y., Cho, S. J., & Yook, K. H. (2010). Effectiveness of a mindfulness-based cognitive therapy program as an adjunct to pharmacotherapy in patients with panic disorder. Journal of Anxiety Disorders, 24(6), 590–595. https://doi.org/10.1016/j.janxdis.2010.03.019CrossRefPubMed

Kim, H., Lim, S. W., Kim, S., Kim, J. W., Chang, Y. H., Carroll, B. J., & Kim, D. K. (2006). Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA, 296(13), 1609–1618. https://doi.org/10.1001/jama.296.13.1609CrossRefPubMed

Kim, M. K., Lee, K. S., Kim, B., Choi, T. K., & Lee, S. H. (2016). Impact of mindfulness-based cognitive therapy on intolerance of uncertainty in patients with panic disorder. Psychiatry Investigation, 13(2), 196–202. https://doi.org/10.4306/pi.2016.13.2.196CrossRefPubMedPubMedCentral

Knuts, I., Esquivel, G., Kenis, G., Overbeek, T., Leibold, N., Goossens, L., & Schruers, K. (2014). Therapygenetics: 5-HTTLPR genotype predicts the response to exposure therapy for agoraphobia. European Neuropsychopharmacology, 24(8), 1222–1228. https://doi.org/10.1016/j.euroneuro.2014.05.007CrossRefPubMed

Lee, E. H., Kim, J. H., & Yu, B. H. (2009). Reliability and validity of the self-report version of the panic disorder severity scale in Korea. Depression and Anxiety, 26(8), E120-123. https://doi.org/10.1002/da.20461CrossRefPubMed

Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., & Murphy, D. L. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274(5292), 1527–1531. https://doi.org/10.1126/science.274.5292.1527CrossRefPubMed

Lester, K. J., & Eley, T. C. (2013). Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biology of Mood & Anxiety Disorders, 3(1), 4. https://doi.org/10.1186/2045-5380-3-4CrossRef

Lester, K. J., Hudson, J. L., Tropeano, M., Creswell, C., Collier, D. A., Farmer, A., Lyneham, H. J., Rapee, R. M., & Eley, T. C. (2012). Neurotrophic gene polymorphisms and response to psychological therapy. Translational Psychiatry, 2, e108. https://doi.org/10.1038/tp.2012.33CrossRefPubMedPubMedCentral

Lester, K. J., Roberts, S., Keers, R., Coleman, J. R., Breen, G., Wong, C. C., Xu, X., Arendt, K., Blatter-Meunier, J., Bogels, S., Cooper, P., Creswell, C., Heiervang, E. R., Herren, C., Hogendoorn, S. M., Hudson, J. L., Krause, K., Lyneham, H. J., McKinnon, A., … Eley, T. C. (2016). Non-replication of the association between 5HTTLPR and response to psychological therapy for child anxiety disorders. British Journal of Psychiatry, 208(2), 182–188. https://doi.org/10.1192/bjp.bp.114.154997CrossRef

Lim, S.-Y., Lee, E.-J., Jeong, S.-W., Kim, H.-C., Jeong, C.-H., Jeon, T.-Y., Yi, M.-S., Kim, J.-M., Jo, H.-J., & Kim, J.-B. (2011). The validation study of Beck Depression Scale 2 in Korean version. Anxiety and Mood, 7(1), 48–53.

Long, H., Liu, B., Hou, B., Wang, C., Li, J., Qin, W., Wang, D., Zhou, Y., Kendrick, K. M., & Yu, C. (2013). The long rather than the short allele of 5-HTTLPR predisposes Han Chinese to anxiety and reduced connectivity between prefrontal cortex and amygdala. Neuroscience Bulletin, 29(1), 4–15.CrossRef

Lonsdorf, T. B., Ruck, C., Bergstrom, J., Andersson, G., Ohman, A., Lindefors, N., & Schalling, M. (2010). The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder. BMC Psychiatry, 10, 99. https://doi.org/10.1186/1471-244X-10-99CrossRefPubMedPubMedCentral

Lueken, U., Straube, B., Wittchen, H.-U., Konrad, C., Ströhle, A., Wittmann, A., Pfleiderer, B., Arolt, V., Kircher, T., & Deckert, J. (2015). Therapygenetics: Anterior cingulate cortex–amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia. Journal of Neural Transmission, 122(1), 135–144.CrossRef

McGowan, O. O. (2020). Pharmacogenetics of anxiety disorders. Neuroscience Letters, 726, 134443. https://doi.org/10.1016/j.neulet.2019.134443CrossRefPubMed

Mendlowicz, M. V., & Stein, M. B. (2000). Quality of life in individuals with anxiety disorders. American Journal of Psychiatry, 157(5), 669–682. https://doi.org/10.1176/appi.ajp.157.5.669CrossRef

Miller, J. J., Fletcher, K., & Kabat-Zinn, J. (1995). Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. General Hospital Psychiatry, 17(3), 192–200. https://www.ncbi.nlm.nih.gov/pubmed/7649463.

Munafo, M. R., Brown, S. M., & Hariri, A. R. (2008). Serotonin transporter (5-HTTLPR) genotype and amygdala activation: A meta-analysis. Biological Psychiatry, 63(9), 852–857. https://doi.org/10.1016/j.biopsych.2007.08.016CrossRefPubMed

Murphy, S. E., Norbury, R., Godlewska, B. R., Cowen, P. J., Mannie, Z. M., Harmer, C. J., & Munafo, M. R. (2013). The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-analysis. Molecular Psychiatry, 18(4), 512–520. https://doi.org/10.1038/mp.2012.19CrossRefPubMed

Myung, W., Lim, S. W., Kim, S., Kim, H., Chung, J. W., Seo, M. Y., Kim, J. W., Carroll, B. J., & Kim, D. K. (2013). Serotonin transporter genotype and function in relation to antidepressant response in Koreans. Psychopharmacology (berl), 225(2), 283–290. https://doi.org/10.1007/s00213-012-2813-yCrossRef

Oh, H., Park, K., Yoon, S., Kim, Y., Lee, S. H., Choi, Y. Y., & Choi, K. H. (2018). Clinical utility of Beck Anxiety Inventory in clinical and nonclinical Korean samples. Frontiers in Psychiatry, 9, 666. https://doi.org/10.3389/fpsyt.2018.00666CrossRefPubMedPubMedCentral

Olsson, C. A., Byrnes, G. B., Lotfi-Miri, M., Collins, V., Williamson, R., Patton, C., & Anney, R. J. (2005). Association between 5-HTTLPR genotypes and persisting patterns of anxiety and alcohol use: Results from a 10-year longitudinal study of adolescent mental health. Molecular Psychiatry, 10(9), 868–876. https://doi.org/10.1038/sj.mp.4001677CrossRefPubMed

Pluess, M., Belsky, J., Way, B. M., & Taylor, S. E. (2010). 5-HTTLPR moderates effects of current life events on neuroticism: Differential susceptibility to environmental influences. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(6), 1070–1074. https://doi.org/10.1016/j.pnpbp.2010.05.028CrossRef

Pollack, M. H., Otto, M. W., Worthington, J. J., Manfro, G. G., & Wolkow, R. (1998). Sertraline in the treatment of panic disorder: A flexible-dose multicenter trial. Archives of General Psychiatry, 55(11), 1010–1016. https://doi.org/10.1001/archpsyc.55.11.1010CrossRefPubMed

Porcelli, S., Fabbri, C., & Serretti, A. (2012). Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. European Neuropsychopharmacology, 22(4), 239–258. https://doi.org/10.1016/j.euroneuro.2011.10.003CrossRefPubMed

Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55.CrossRef

Segal, Z. V., Williams, J. M., & Teasdale, J. D. (2002). Mindfulness-based cognitive therapy for depression: A new approach to preventing relapse. Guilford Press.

Shapiro, S. L., Carlson, L. E., Astin, J. A., & Freedman, B. (2006). Mechanisms of mindfulness. Journal of Clinical Psychology, 62(3), 373–386. https://doi.org/10.1002/jclp.20237CrossRefPubMed

Shear, M. K., Rucci, P., Williams, J., Frank, E., Grochocinski, V., Vander Bilt, J., Houck, P., & Wang, T. (2001). Reliability and validity of the panic disorder severity scale: Replication and extension. Journal of Psychiatric Research, 35(5), 293–296.CrossRef

Simon, N. M., Safren, S. A., Otto, M. W., Sharma, S. G., Lanka, G. D., & Pollack, M. H. (2002). Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. Journal of Affective Disorders, 69(1–3), 201–208. https://www.ncbi.nlm.nih.gov/pubmed/12103467.

Singh, S. K., & Gorey, K. M. (2018). Relative effectiveness of mindfulness and cognitive behavioral interventions for anxiety disorders: Meta-analytic review. Social Work in Mental Health, 16(2), 238–251.CrossRef

Vøllestad, J., Nielsen, M. B., & Nielsen, G. H. (2012). Mindfulness- and acceptance-based interventions for anxiety disorders: A systematic review and meta-analysis. British Journal of Clinical Psychology, 51(3), 239–260. https://doi.org/10.1111/j.2044-8260.2011.02024.xCrossRef

Weissman, M. M., Bland, R. C., Canino, G. J., Faravelli, C., Greenwald, S., Hwu, H. G., Joyce, P. R., Karam, E. G., Lee, C. K., Lellouch, J., Lepine, J. P., Newman, S. C., Oakley-Browne, M. A., Rubio-Stipec, M., Wells, J. E., Wickramaratne, P. J., Wittchen, H. U., & Yeh, E. K. (1997). The cross-national epidemiology of panic disorder. Archives of General Psychiatry, 54(4), 305–309. https://www.ncbi.nlm.nih.gov/pubmed/9107146.

Yonkers, K. A., Bruce, S. E., Dyck, I. R., & Keller, M. B. (2003). Chronicity, relapse, and illness–course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow-up. Depression and Anxiety, 17(3), 173–179. https://doi.org/10.1002/da.10106CrossRefPubMed

Yoshida, K., Ito, K., Sato, K., Takahashi, H., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., Tezuka, T., Suzuki, T., Ohkubo, T., Sugawara, K., & Otani, K. (2002). Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26(2), 383–386. https://doi.org/10.1016/s0278-5846(01)00287-1CrossRef

Titel: Effectiveness of Mindfulness-Based Cognitive Therapy for Positive Clinical Outcome in Panic Disorder: a 5-year Longitudinal Study
Auteurs: Minji Bang
Borah Kim
Kang Soo Lee
Tai Kiu Choi
Sang-Hyuk Lee
Publicatiedatum: 02-07-2021
Uitgeverij: Springer US
Gepubliceerd in: Mindfulness / Uitgave 9/2021
Print ISSN: 1868-8527
Elektronisch ISSN: 1868-8535
DOI: https://doi.org/10.1007/s12671-021-01667-9

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Objectives

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 9/2021

The Buddha’s Awakening

A Delphi Study Investigating Clinicians’ Views on Access to, Delivery of, and Adaptations of MBCT in the UK Clinical Settings

Subsurface Confinement: Evidence from Submariners of the Benefits of Mindfulness

Using fNIRS to Examine Neural Mechanisms of Change Associated with Mindfulness-Based Interventions for Stress and Trauma: Results of a Pilot Study for Women

Mindfulness Versus Cognitive Reappraisal: the Impact of Mindfulness-Based Stress Reduction (MBSR) on the Early and Late Brain Potential Markers of Emotion Regulation

Shame, Self-Compassion, and Valued Living Among Survivors of Interpersonal Violence